Sugi Predict

Sugi Predict / Compounds / SCHEMBL865744

SCHEMBL865744

SCHEMBL865744

O=Cc1ccc(OCc2ccc(Br)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.67
▸ MAOA P21397 5/20 0.67
▸ APP P05067 1/20 0.61
▸ RAB9A P51151 2/20 0.59
▸ RXRA P19793 1/20 0.58
▸ RXRB P28702 1/20 0.58
▸ CA12 O43570 1/20 0.57
▸ CA1 P00915 1/20 0.57
▸ CA2 P00918 1/20 0.57
▸ CA7 P43166 1/20 0.57
▸ CA9 Q16790 1/20 0.57
▸ SIRT2 Q8IXJ6 1/20 0.56
▸ SIRT1 Q96EB6 1/20 0.56
▸ SIRT3 Q9NTG7 1/20 0.56
▸ SIRT5 Q9NXA8 1/20 0.56
▸ FFAR1 O14842 2/20 0.55
▸ FFAR4 Q5NUL3 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16295330 1.00 MAOB (0.67) MAOBMAOAAPPRAB9ARXRA
SCHEMBL11614936 0.91 RAB9A (0.69) MAOBMAOAAPPRAB9AALDH1A1
SCHEMBL23223734 0.91 RAB9A (0.69) MAOBMAOAAPPRAB9AALDH1A1
SCHEMBL28271245 0.86 RAB9A (0.59) MAOBMAOAAPPRAB9AALDH1A1
SCHEMBL2399080 0.84 APP (0.80) MAOBMAOAAPPRXRARXRB
SCHEMBL865349 0.84 RAB9A (0.71) MAOBMAOARAB9AFFAR1FFAR4
SCHEMBL8589028 0.84 RAB9A (0.61) MAOBMAOAAPPRAB9AALDH1A1
SCHEMBL12578126 0.83 ALDH1A1 (0.57) MAOBMAOARAB9AFFAR1FFAR4
SCHEMBL28625523 0.83 ALDH1A1 (0.57) MAOBMAOARAB9AFFAR1FFAR4
SCHEMBL6410996 0.82 RXRA (0.55) MAOBMAOAAPPRAB9ARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5024352-A — — None — — JP disclosed
CN-108912029-B Nitrogen-containing heterocyclic amide derivative and use thereof 广东东阳光药业有限公司 2021-10-01 — — CN disclosed
CN-108912029-A Nitrogen-containing heterocycle amide derivatives and application thereof 广东东阳光药业有限公司 2018-11-30 — — CN disclosed
EP-2794620-B1 BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS NAT UNIV SINGAPORE (SG) 2017-11-15 — — EP disclosed
US-9423395-B2 Fluorescent cell cycle probe having M-phase specificity NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-08-23 — — US disclosed
US-9423395-B2 Fluorescent cell cycle probe having M-phase specificity NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-08-23 — — US disclosed
US-9423396-B2 Bodipy structure fluorescence probes for diverse biological applications NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-08-23 — — US disclosed
US-9423396-B2 Bodipy structure fluorescence probes for diverse biological applications NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-08-23 — — US disclosed
US-9296711-B2 Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1) HOFFMAN-LA ROCHE INC. (US) 2016-03-29 — — US disclosed
CN-102382037-B Phenylpropionic acid compound and method for making thereof and pharmaceutical use INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2016-01-20 — — CN disclosed
US-7790896-B2 RNA-selective probes for live cell imaging of nuclear structure and function NEW YORK UNIVERSITY (US) 2010-09-07 — — US disclosed
US-7790896-B2 RNA-selective probes for live cell imaging of nuclear structure and function NEW YORK UNIVERSITY (US) 2010-09-07 — — US disclosed
US-20100216762-A1 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof ABBOTT LABORATORIES (US) 2010-08-26 — — US disclosed
US-20100216762-A1 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof ABBOTT LABORATORIES (US) 2010-08-26 — — US disclosed
WO-2010093704-A1 AGONISTS AND ANTAGONISTS OF THE S1P5 RECEPTOR, AND METHODS OF USES THEREOF ABBOTT LABORATORIES (US) 2010-08-19 — — WO disclosed
US-20080064037-A1 RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION NEW YORK UNIVERSITY (US) 2008-03-13 — — US disclosed
US-20080064037-A1 RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION NEW YORK UNIVERSITY (US) 2008-03-13 — — US disclosed
US-6416861-B1 COMBINATORIAL CHEMISTRY NORTHWESTERN UNIVERSITY 2002-07-09 — — US disclosed
WO-2000049022-A2 ORGANOSILICON COMPOUNDS AND USES THEREOF NORTHWESTERN UNIVERSITY (US) 2000-08-24 — — WO disclosed
JP-H0524352-A HEAT-SENSITIVE RECORDING MATERIAL MITSUBISHI PAPER MILLS LTD 1993-02-02 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064037-A1 RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION SNRPE, HNRNPUL2, EFTUD2 MAOB 4230/4885MAOA 4571/4885APP 4763/4885
US-20100216762-A1 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof S1PR5, LPAR5, S1PR1 MAOB 2578/4885MAOA 1922/4885APP 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.